Related Experiment Videos
[Giant-cell tumor of bone]
C P Calçada1, I Silva, H Cunha
1Departamento de Radioterapia, Centro de Oncologia do Porto.
Acta Medica Portuguesa
|October 17, 1998
Summary
Giant-cell bone tumors are rare, with malignant forms accounting for 0.5% of primary bone cancers. This report details a rare ischium tumor successfully treated with radiotherapy, showing no disease recurrence after ten years.
Area of Science:
- Orthopedic Oncology
- Radiotherapy Research
- Bone Tumor Pathology
Background:
- Giant-cell tumors of bone (GCTB) are uncommon neoplasms, with malignant variants representing a small fraction of primary bone malignancies.
- Malignant GCTB constitute approximately 0.5% of all primary malignant bone tumors, highlighting their rarity.
- Unusual tumor localization, such as in the ischium, presents unique diagnostic and therapeutic challenges.
Observation:
- This case report focuses on a patient with a GCTB in an atypical location (ischium), a site affected in only about 0.6% of such cases.
- Due to the tumor's extensive local spread, radical surgical intervention with significant functional deficits was deemed necessary.
- The patient received radiotherapy as the primary treatment modality.
Findings:
- The patient treated with radiotherapy alone for a malignant GCTB of the ischium remains alive ten years post-treatment.
- There is no clinical evidence of disease recurrence in the patient after a decade.
- The patient has maintained full functional capacity without impairments.
Implications:
- Radiotherapy can be an effective treatment for malignant giant-cell bone tumors in challenging locations, potentially avoiding extensive surgery.
- Long-term follow-up demonstrates the durable efficacy of radiotherapy in managing rare malignant bone tumors.
- This case suggests that radiotherapy alone may be a viable option for select patients with locally advanced GCTB, preserving function.